Nickolas to lead Division of Bone and Mineral Diseases
Thomas Nickolas, MD, a respected clinical nephrologist and researcher focused on kidney disease and bone health, has been named the next director of the Division of Bone and Mineral Diseases in the Department of Medicine at Washington University School of Medicine in St. Louis.
Learning the French way to better health
After a pandemic pause, WashU undergrads were back at Hôpital Pasteur on the French Riviera over the summer, learning why the French live healthier and longer than anyone else in the industrialized world.
Debilitating elbow contracture to get closer look aided by machine learning
A researcher in the McKelvey School of Engineering will study the effects of physical therapy and anti-inflammatory treatments on an elbow injury with a $2.4 million grant from the National Institutes of Health (NIH).
Cooper named fellow of American Society for Cell Biology
John Cooper, MD, PhD, the Alan A. and Edith L. Wolfe Professor of Biochemistry and Molecular Biophysics at Washington University School of Medicine in St. Louis, has been elected a fellow of the American Society for Cell Biology.
Ross honored by Association of American Medical Colleges
Will Ross, MD, the associate dean for diversity and the Alumni Endowed Professor of Medicine at WashU Medicine, has received the 2024 Louis W. Sullivan, MD, Award from the Association of American Medical Colleges.
Potential Type 1 diabetes treatment may stem from outsmarting immune cells
Cory Berkland, a researcher at Washington University, will lead preclinical diabetes research with a $2.6 million grant from The Leona M. and Harry B. Helmsley Charitable Trust.
New genomic surveillance tools could help efforts to eliminate damaging parasitic infections
Researchers at WashU Medicine have developed a new genomic-based approach that could aid global efforts to eliminate lymphatic filariasis, a parasitic roundworm infection spread by mosquitoes.
Viruses found hiding in lungs’ immune cells long after initial illness
A mouse study by researchers at WashU Medicine shows that lingering respiratory viruses set the stage for chronic lung disease, and eliminating infected cells reduces signs of chronic lung damage.
Grant supports research to develop gene therapy for cystic fibrosis
Researchers at Washington University School of Medicine in St. Louis have received a three-year $2.6 million grant from the Cystic Fibrosis Foundation to develop gene therapies for cystic fibrosis.
$12 million grant aimed at probing how vaccines induce lasting immunity
Researchers at WashU Medicine received funding from the National Institute of Allergy and Infectious Diseases to identify the immune factors responsible for long-lasting protection against disease.
Older Stories